Unknown

Dataset Information

0

Preconditioning via angiotensin type 2 receptor activation improves therapeutic efficacy of bone marrow mononuclear cells for cardiac repair.


ABSTRACT: BACKGROUND: The therapeutic efficiency of bone marrow mononuclear cells (BMMNCs) autologous transplantation for myocardial infarction (MI) remains low. Here we developed a novel strategy to improve cardiac repair by preconditioning BMMNCs via angiotensin II type 2 receptor (AT2R) stimulation. METHODS AND RESULTS: Acute MI in rats led to a significant increase of AT2R expression in BMMNCs. Preconditioning of BMMNCs via AT2R stimulation directly with an AT2R agonist CGP42112A or indirectly with angiotensin II plus AT1R antagonist valsartan led to ERK activation and increased eNOS expression as well as subsequent nitric oxide generation, ultimately improved cardiomyocyte protection in vitro as measured by co-culture approach. Intramyocardial transplantation of BMMNCs preconditioned via AT2R stimulation improved survival of transplanted cells in ischemic region of heart tissue and reduced cardiomyocyte apoptosis and inflammation at 3 days after MI. At 4 weeks after transplantation, compared to DMEM and non-preconditioned BMMNCs group, AT2R stimulated BMMNCs group showed enhanced vessel density in peri-infarct region and attenuated infarct size, leading to global heart function improvement. CONCLUSIONS: Preconditioning of BMMNCs via AT2R stimulation exerts protective effect against MI. Stimulation of AT2R in BMMNCs may provide a new strategy to improving therapeutic efficiency of stem cells for post MI cardiac repair.

SUBMITTER: Xu Y 

PROVIDER: S-EPMC3858344 | BioStudies | 2013-01-01

REPOSITORIES: biostudies

Similar Datasets

1000-01-01 | S-EPMC4549048 | BioStudies
1000-01-01 | S-EPMC5770128 | BioStudies
2019-01-01 | S-EPMC6341224 | BioStudies
1000-01-01 | S-EPMC2905034 | BioStudies
2012-01-01 | S-EPMC3246529 | BioStudies
1000-01-01 | S-EPMC3501976 | BioStudies
2014-01-01 | S-EPMC3928273 | BioStudies
2017-01-01 | S-EPMC5678778 | BioStudies
2018-01-01 | S-EPMC5903991 | BioStudies
2020-01-01 | S-EPMC7465503 | BioStudies